small molecule therapeutic for acute leukemia (Zhejiang University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Haimen Biopolar Pharmaceutical Technology)
N/A
Report date: 2025/03/20 09:48:53
NME
Base Information
Drug Namesmall molecule therapeutic for acute leukemia (Zhejiang University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Haimen Biopolar Pharmaceutical Technology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang University
China Registration ClassN/A
Develop Information
Active CompaniesBiopolar Hongye (Nantong) Pharmaceutical Co LtdZhejiang UniversityShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A